Gas producer Parkmead Group (LON: PMG) generated revenues of £4m from its remaining gas assets in the year to June 2025. There was a £11.8m accounting gain on the disposal of Parkmead (E&P). Cash was £13.2m at year-end and there are up to £120m of contingent payments. This will provide finance for moves into renewable energy and for taking advantage of gas opportunities. The share price increased 14.5% to 15p.
Womenswear retailer Sosandar (LON: SOS) is gaining momentum this year. Interim revenues were 15% higher at £18.7m, while sales were 28% ahead on the company’s website. Sales to Marks & Spencer were hit by that retailer’s cyber incident, but they have started again. The six stores are loss-making, but the first two are moving towards breakeven. The interim loss increased from £700,000 to £1.1m, but a full year pre-tax profit is anticipated. Net cash was £7.7m at the end of September. The share price recovered 4.56% to 6.875p.
Defence services provider RC Fornax (LON: RCFX) has secured a framework agreement in the space sector. Initial revenues are £370,000 over six months and there could be follow-on revenues. It will retain ownership of IP. The share price rose 6.84% to 6.25p.
Engineering services provider Renew (LON: RNWH) managed to negotiate weaker demand for rail services and still improve operating profit, although higher interest costs meant underlying pre-tax profit dipped from £69.9m to £68.1m. Electricity and renewables services acquisitions added to the figures. Electricity transmission and water services provide significant potential growth. Net cash was £6.2m at the end of September, but that was before the acquisition of Emerald Power. The bank facility has increased from £120m to £140m for a four-year term. This provides funding for further acquisitions. The share price is 4% higher at 949.5p.
FALLERS
CelLBxHealth (LON: CLBX) has raised £6.8m at 1p/share and could raise up to £1m more from a retail offer. A capital reorganisation will reduce the nominal value of the shares so that they can be issued at this price. There will be £1.9m spent on R&D, £1m for sales and market and £1.2m for reorganisation and IT systems. The cancer diagnostics company will progress partnerships and reduce annual operating costs by more than £5.9m. Ther will also be development of additional assays for the Parsortix platform. The share price slid 31.3% to 1.1p.
Security technology supplier Thruvision (LON:THRU) grew interim revenues 36% to £2.6m, even though retail revenues were lower. Cash was £2.1m at the end of September 2025. The second half will be tougher than expected and Allenby has reduced its full year revenues forecast from £8m to £5m, while the loss is raised from £2.21m to £3.55m. There will still be cash by the end of March 2026. The share price fell 27.3% to 0.6p.
Engineer Pipehawk (LON: PIP) shares initially rose on the release of full year results but are now down 9.68% to 1.4p. There was a drop in revenues, but continuing revenues grew 27% to £3.7m. The loss was reduced from £1.64m to £310,000. Management is seeking business outside the UK, where utilities and government spending has been delayed.
Consumer goods supplier Supreme (LON: SUP) reported interims boosted by acquisitions and vape sales were higher than expected. This offset lower electricals sales. Revenues were 17% higher at £132.6m. Pre-tax profit declined from £12.9m to £12.2m. The dividend was reduced to 1.6p/share in line with earnngs. Net debt was £4.1m at the end of September 2025. The banning of disposable vapes led to a move to reusable pods and there was an initial boost to sales in the period. This may not continue in the second half, but there will be greater contributions from acquisitions. The share price declined 5.36% to 159p.